Prof. Dr. med. Oliver Schnell

Lehrstuhl für Neurochirurgie

Technical report: surgical preparation of human brain tissue for clinical and basic research (2023) Straehle J, Ravi VM, Heiland DH, Galanis C, Lenz M, Zhang J, Neidert NN, et al. Journal article Quality of Life After Poor-Grade Aneurysmal Subarachnoid Hemorrhage (2023) Goldberg J, Z'Graggen WJ, Hlavica M, Branca M, Marbacher S, D'Alonzo D, Fandino J, et al. Journal article Intraoperative Visualization of Flow in Direct Cerebrospinal Fluid-Venous Fistulas Using Intrathecal Fluorescein (2023) Häni L, El Rahal A, Fung C, Volz F, Kraus LM, Lützen N, Urbach H, et al. Journal article Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group (2023) Karschnia P, Young JS, Dono A, Häni L, Sciortino T, Bruno F, Juenger ST, et al. Journal article Surgical closure of spinal cerebrospinal fluid leaks improves symptoms in patients with superficial siderosis (2023) El Rahal A, Haupt B, Fung C, Cipriani D, Häni L, Lützen N, Dobrocky T, et al. Journal article Multiomic spatial landscape of innate immune cells at human central nervous system borders (2023) Sankowski R, Süß P, Benkendorff A, Böttcher C, Fernandez-Zapata C, Chhatbar C, Cahueau J, et al. Journal article Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial (2023) Weller J, Schäfer N, Schaub C, Tzaridis T, Zeyen T, Schneider M, Potthoff AL, et al. Journal article Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-up (2023) Pertz M, Schlömer S, Seidel C, Hentschel B, Löffler M, Schackert G, Krex D, et al. Journal article Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial (2022) Zeyen T, Potthoff AL, Nemeth R, Heiland DH, Burger MC, Steinbach JP, Hau P, et al. Journal article T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 (2022) Ravi VM, Neidert N, Will P, Joseph K, Maier JP, Kückelhaus J, Vollmer L, et al. Journal article